A Brief Introduction to Monte Carlo Simulation

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.40, Iss.1, 2001-01, pp. : 15-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Monte Carlo Simulation for Modelling Outcomes of AIDS Treatment Regimens

By Richter A.

PharmacoEconomics, Vol. 20, Iss. 4, 2002-04 ,pp. : 215-224

Adis International

Access to resources Recommend Favorite

Parameters affecting drug release from inert matrices. 1: Monte Carlo simulation

By Villalobos Rafael Viquez Hugo Hernández Beatriz Ganem Adriana Melgoza Luz María Young Paul M.

Pharmaceutical Development and Technology, Vol. 17, Iss. 3, 2012-06 ,pp. : 344-352

Informa Healthcare

Access to resources Recommend Favorite

Parametric and Nonparametric Population Methods: Their Comparative Performance in Analysing a Clinical Dataset and Two Monte Carlo Simulation Studies

By Bustad Aida

Clinical Pharmacokinetics, Vol. 45, Iss. 4, 2006-01 ,pp. : 365-383

Adis International

Access to resources Recommend Favorite

Combining Physiologically Based Pharmacokinetic Modeling with Monte Carlo Simulation to Derive an Acute Inhalation Guidance Value for Trichloroethylene

By Simon T.W.

Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 3, 1997-12 ,pp. : 257-270

Academic Press

Access to resources Recommend Favorite

A pharmacokinetic/pharmacodynamic analysis of a standard voriconazole regimen in different CYP2C19 genotypes by Monte Carlo simulation

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 5, 2015-01 ,pp. : 306-309

Govi-Verlag

Access to resources Recommend Favorite